Lifevantage (LFVN) insider report: 12,349 stock units and 18,524 PRSUs
Rhea-AI Filing Summary
Lifevantage Corp (LFVN) reporting person Kristen Cunningham, Chief Sales Officer, received equity awards on 08/26/2025. The filing shows a grant of 12,349 stock units (each convertible to one share) and 18,524 performance restricted stock units (PRSUs) representing target-level awards. Following the transactions, Cunningham beneficially owns 116,351 shares and 18,524 PRSU-equivalent shares reported as direct ownership. The stock units vest over time subject to continued service, and the PRSUs vest only if specified performance criteria are met, with potential payout up to 200% of target.
Positive
- 12,349 stock units awarded to the Chief Sales Officer, aligning compensation with stock ownership
- 18,524 PRSUs granted which tie pay to performance and may pay up to 200% of target, incentivizing achievement
- Clear multi-year vesting schedule disclosed, supporting retention through 2028
Negative
- PRSUs vest only if specified performance criteria are met, so actual issuance could be zero if targets are unmet
- Awarded units could dilute existing shareholders if and when converted into common stock
- Filing lacks the specific financial performance targets and measurement periods, limiting assessment of materiality
Insights
TL;DR: Insider received time- and performance-based equity awards; routine for executive compensation.
The grant of 12,349 stock units plus 18,524 PRSUs aligns executive pay with shareholder outcomes by combining service-based vesting and performance conditions. Vesting schedules are multi-year and contingent on continued service; PRSUs further require achievement of defined financial metrics and may pay up to 200% at maximum performance. This is a standard mechanism to retain senior sales leadership and incentivize target achievement; no immediate cash transfer or exercise price is reported.
TL;DR: Transaction is disclosure of granted equity units, not a market sale or purchase.
The Form 4 records awards rather than open-market transactions. The reported $0 price and description indicate equity grants (stock units and PRSUs) rather than purchases. Investors should note these awards increase potential future share issuance if vested and earned, but the filing contains no information about timing of performance measurement periods or the precise financial targets, only vesting dates and payout multiplier at maximum performance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Restricted Stock Units | 18,524 | $0.00 | -- |
| Grant/Award | Common Stock | 12,349 | $0.00 | -- |
Footnotes (1)
- This reflects a stock unit award, in which each stock unit represents a right to receive one share of issuer common stock, which award will vest, subject to the reporting person's continued service with the issuer, as follows: (i) 5/12 of the total number of units will vest on September 10, 2026 and (ii) the remaining units will vest in equal installments as of the 10th day of the third month of each of the seven calendar quarters thereafter. Each Performance Restricted Stock Unit ("PRSU") represents a right to receive one share of issuer common stock, with the total number of units reflecting the number that are eligible to be earned at target-level performance achievement. Upon achievement of the maximum level of the applicable performance criteria, the reporting person may become eligible to earn 200% of the target number of units. The PRSUs will vest only to the extent the specified financial performance criteria are achieved and subject to the reporting person's continued service with the issuer, as follows: (i) 34% of the earned award will vest on September 10, 2026 (ii) 33% of the earned award will vest on September 10, 2027 and (iii) 33% of the earned award will vest on September 10, 2028.